FDA Adverse Event Malfunction Summary report: N

INRATIO

MDR report key: 1699031 · Received May 18, 2010

Report

Report Number
2027969-2010-00596
Event Type
Malfunction
Date Received
May 18, 2010
Date of Event
April 22, 2010
Report Date
May 18, 2010
Manufacturer
BIOSITE INCORPORATED
Product Code
GJS
PMA / PMN Number
K021923
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

DISCREPANT RESULTS (ACCURACY) COMPARISON OF INRATIO TEST WITH LAB RESULTS PROVIDED BY END-USER AT TIME COMPLAINT WAS FILED: DATE: (B)(6)2010; INRATIO METER=1.8 INR; REFERENCE= 2.5 INR; MEAN= 2.15; CONFIDENCE LIMITS= 1.4-3.1. TESTS ARE PERFORMED SIMULTANEOUSLY BETWEEN TWO READINGS. THE MEAN OF THE INRATIO METER AND COMPARATIVE SYSTEM INR WERE CALCULATED. BOTH INRATIO AND REFERENCE VALUES ARE WITHIN THE CONFIDENCE LIMITS FOR INR TESTING. THE RESULTS ARE NOT CONSIDERED DISCREPANT WITHIN THE CONTEXT OF THE DOCUMENTED VARIABILITY FOR INR TESTING. INR REPORTED HAVE MET THE CRITERIA FOR ACCURACY. NO FURTHER INVESTIGATION WILL BE PURSUED. DATA ANALYSIS REVEALED INR'S REPORTED BY END USER HAS MET ACCURACY CRITERIA. THE RESULTS ARE NOT CONSIDERED DISCREPANT WITHIN THE CONTEXT OF THE DOCUMENTED VARIABILITY FOR INR TESTING. AS OF 05/13/2010, 26 DISCREPANT RESULTS COMPLAINTS WERE REPORTED FOR LOT #225323, YIELDING A COMPLAINT RATE OF 0.015%. DUE TO THIS LOW OCCURRENCE RATE, BELOW THE ACTION THRESHOLDS MONITORED BY QA FOR CORRECTIVE ACTION (>0.07%) NO FURTHER ACTION IS REQUIRED AT THIS TIME. ON GOING TRENDING SHALL BE PERFORMED TO DETERMINE IF FURTHER ACTION IS WARRANTED.

Description of Event or Problem · 1

CALLER ALLEGED DISCREPANT RESULTS BETWEEN COMPARISON METER RESULTS. RESULTS AS FOLLOWS: DATE: (B)(6)2010, (B)(6)2010; TEST 1: 2.4, 1.8; TEST 2: 2.5, 2.X.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INRATIO PROTHROMBIN TIME TEST GJS BIOSITE INCORPORATED 100071 225323

Patients

Seq Age Sex Outcome Treatment
1